Analysed AVACTA GROUP PLC (AVCTF:OTCMKTS) News Sources
Avacta's pre|CISION Mechanism for Payload Delivery Shows Key Advantages Compared to an Antibody Drug Conjugate in Innovative AI-Driven Analysis
24-02-2026
yahoo.com
With 75% institutional ownership, Avacta Group Plc (LON:AVCT) is a favorite amongst the big guns
15-02-2026
yahoo.com
Avacta Announces U.S. Food and Drug Administration Clearance of the Investigational New Drug (IND) Application for the Second pre|CISION® Medicine, FAP-Exatecan (AVA6103)
21-01-2026
yahoo.com
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers
17-12-2025
yahoo.com
Avacta presents first preclinical data from dual payload pre|CISION® medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
25-10-2025
yahoo.com
Avacta Therapeutics Presents Compelling Phase 1a Data for Faridoxorubicin and the pre|CISION® Platform at the European Society of Medical Oncology Annual Congress
19-10-2025
yahoo.com
What is the current price of AVACTA GROUP PLC (AVCTF:OTCMKTS)?
The current price of AVACTA GROUP PLC (AVCTF:OTCMKTS) is $0.8931.
AVACTA GROUP PLC (AVCTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of AVACTA GROUP PLC (AVCTF:OTCMKTS) since the previous trading day is $0.026.
AVACTA GROUP PLC (AVCTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of AVACTA GROUP PLC (AVCTF:OTCMKTS) since the previous trading day is 2.9985%.
What is the most recent average sentiment score for AVACTA GROUP PLC (AVCTF:OTCMKTS)?
The most recent average sentiment score for AVACTA GROUP PLC (AVCTF:OTCMKTS) is 88 out of 100.
What is the most recent average sentiment for AVACTA GROUP PLC (AVCTF:OTCMKTS)?
The most recent sentiment for AVACTA GROUP PLC (AVCTF:OTCMKTS) is .
SEC-8K** Filing Available For AVACTA GROUP PLC (AVCTF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.